Product Information
ENALAPRIL 1 MG/ML ORAL SOLN is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $0.7946 per ML under NDC 52536040101. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Sep 20, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536040101
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA208686FDA Approved
9/20/2016
TE Code
AB
On Market Since
4/8/2024
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7946 per ML |
|---|---|
| All-time high | $1.6522 (Jul 10, 2024) |
| All-time low | $0.7946 (Sep 23, 2026) |
| 52-week high | $1.1387 |
| 52-week low | $0.7946 |
| Median price | $1.1169 |
| Average price | $1.1601 |
| Largest weekly change | +13.1% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Wilshire Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enalapril maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL 1 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL 1 MG/ML ORAL SOLN, manufactured by Wilshire Pharmaceuticals Inc., is $0.7946 per ML (NDC 52536040101), effective Sep 30, 2026.
How has the price of ENALAPRIL 1 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has declined 51.9%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for ENALAPRIL 1 MG/ML ORAL SOLN?
Since Jul 10, 2024, the NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has ranged from a low of $0.7946 (Sep 23, 2026) to a high of $1.6522 (Jul 10, 2024), with a median of $1.1169 per ML.
Are there cheaper alternatives to ENALAPRIL 1 MG/ML ORAL SOLN?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENALAPRIL 1 MG/ML ORAL SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures ENALAPRIL 1 MG/ML ORAL SOLN?
ENALAPRIL 1 MG/ML ORAL SOLN (NDC 52536040101) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.